• Basel Medical Group priced a registered direct offering of 6,000,000 units at US$ 1.33 per unit.
• Each unit includes one ordinary share or one Pre-Funded Warrant, plus one Common Warrant to buy one ordinary share.
• Common Warrants become exercisable immediately at 110% of the unit price, expire five years from issuance.
• Pre-Funded Warrants carry a US$ 0.01 exercise price, remain exercisable until fully exercised, subject to 4.99% or 9.99% ownership caps.
• Offering implies 6,000,000 Common Warrants outstanding; ordinary shares outstanding rise to 7,582,111 immediately upon completion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081317PRIMZONEFULLFEED9842380) on October 08, 2026, and is solely responsible for the information contained therein.